Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.

Michael Borre; Matthew Smith; Per Rathenborg; Patrick Werbrouck; Hendrik van Poppel; Axel Heidenreich; Peter Iversen; Johan Braeckman; Jiri Heracek; Edwina Baskin-Bey; Taoufik Ouatas; Frank Perabo; D. Phung; Benoit Baron; Mohammad Hirmand; Bertrand Tombal

Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.

Michael Borre, Matthew Smith, Per Rathenborg, Patrick Werbrouck, Hendrik van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, D. Phung, Benoit Baron, Mohammad Hirmand, Bertrand Tombal

Department of Urology

Original language	English
Article number	P060
Journal	European Urology Supplements
Volume	13
Issue number	131
Pages (from-to)	131
ISSN	1569-9056
Publication status	Published - 2014

Cite this

Borre, M., Smith, M., Rathenborg, P., Werbrouck, P., van Poppel, H., Heidenreich, A., Iversen, P., Braeckman, J., Heracek, J., Baskin-Bey, E., Ouatas, T., Perabo, F., Phung, D., Baron, B., Hirmand, M., & Tombal, B. (2014). Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study. European Urology Supplements, 13(131), 131. Article P060.

Borre, M, Smith, M, Rathenborg, P, Werbrouck, P, van Poppel, H, Heidenreich, A, Iversen, P, Braeckman, J, Heracek, J, Baskin-Bey, E, Ouatas, T, Perabo, F, Phung, D, Baron, B, Hirmand, M & Tombal, B 2014, 'Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.', European Urology Supplements, vol. 13, no. 131, P060, pp. 131.

@article{85ed5e44f9764f07838e3edd278760ce,

title = "Enzalutamide monotherapy in patients with hormone-na{\"i}ve prostate cancer: 1.year extended follow-up of a phase 2 study.",

author = "Michael Borre and Matthew Smith and Per Rathenborg and Patrick Werbrouck and {van Poppel}, Hendrik and Axel Heidenreich and Peter Iversen and Johan Braeckman and Jiri Heracek and Edwina Baskin-Bey and Taoufik Ouatas and Frank Perabo and D. Phung and Benoit Baron and Mohammad Hirmand and Bertrand Tombal",

year = "2014",

language = "English",

volume = "13",

pages = "131",

journal = "European Urology Supplements",

issn = "1569-9056",

publisher = "Elsevier BV",

number = "131",

}

TY - ABST

T1 - Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.

AU - Borre, Michael

AU - Smith, Matthew

AU - Rathenborg, Per

AU - Werbrouck, Patrick

AU - van Poppel, Hendrik

AU - Heidenreich, Axel

AU - Iversen, Peter

AU - Braeckman, Johan

AU - Heracek, Jiri

AU - Baskin-Bey, Edwina

AU - Ouatas, Taoufik

AU - Perabo, Frank

AU - Phung, D.

AU - Baron, Benoit

AU - Hirmand, Mohammad

AU - Tombal, Bertrand

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

SN - 1569-9056

VL - 13

SP - 131

JO - European Urology Supplements

JF - European Urology Supplements

IS - 131

M1 - P060

ER -